Clinical trial
A Randomized, Open-label, Two-period, Double Crossover, Single Center Study to Evaluate the Effect of High-fat Diet on the Pharmacokinetics of SY-004 in Healthy Subjects
NCT04907006 is registered in ClinicalTrials.gov with Suzhou Yabao Pharmaceutical R&D Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Open-label, Two-period, Double Crossover, Single Center Study to Evaluate the Effect of High-fat Diet on the Pharmacokinetics of SY-004 in Healthy Subjects
- Lead sponsor
- Suzhou Yabao Pharmaceutical R&D Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 2021
- Completion date
- October 11, 2021
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes